MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-CG-14-0045224
Natcure Biotech Private Limited - pharma in Raipur, Chhattisgarh, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹9.09 Cr
▲ 15% YoY
Net loss · FY 2024
₹73.15 Lakh
Net margin -8%
EBITDA · FY 2024
₹1.07 Cr
EBITDA margin 11.8%
Authorised capital
₹2.5 Cr
Registered with MCA
Paid-up capital
₹2.3 Cr
Issued & subscribed
Open charges
₹8.08 Cr
Secured borrowings
Company age
7 yrs
Est. 2019
Employees · EPFO
98
Provident fund records
About Natcure Biotech Private Limited
Data last updated:
Natcure Biotech Private Limited is a private limited company based in Raipur, Chhattisgarh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 19 June 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Chhattisgarh, under CIN U24110CT2019PTC009360. Its GSTIN is 22AAGCN5770R1ZV (Chhattisgarh).
The company has an authorised share capital of ₹2.5 Cr and a paid-up capital of ₹2.3 Cr. It is led by directors including Shyam Sundar Agrawal and Anil Kumar Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No.7 3rd Floor Hanuman Nagar Kalibadi, Raipur, Chhattisgarh, India – 492001.
As per the financials filed for FY 2024, the company reported a revenue of ₹9.09 Cr, a growth of 15% compared to the previous year. For the same year it recorded a net loss of ₹73.15 Lakh (net margin -8%) and EBITDA of ₹1.07 Cr (EBITDA margin 11.8%). Revenue has grown at a compounded annual rate (CAGR) of 984% over three years.
The company has about 98 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹8.08 Cr on record. Court records list 2 cases involving the company, including 2 filed by the company; 1 case is pending.
Natcure Biotech Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-CG-14-0045224). For more details, the company can be reached via its website natcurebiotech.com.
Company details
CIN U24110CT2019PTC009360
Registration Number 009360
Incorporation Date 19 June 2019
ROC Chhattisgarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Small
Udyam Registration UDYAM-CG-14-0045224
Recognitions & Rankings of Natcure Biotech
Contact details
Natcure Biotech Private Limited's registered office is in Raipur, Chhattisgarh. Its website is natcurebiotech.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressHouse No.7 3rd Floor Hanuman Nagar Kalibadi, Raipur, Chhattisgarh, India – 492001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Natcure Biotech Private Limited, buy the company report.
Comprehensive company report
Natcure Biotech Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Natcure Biotech is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Natcure Biotech Private Limited, buy the company report.
Financials of Natcure Biotech Private Limited
FY 2025 filings availableNatcure Biotech Private Limited reported revenue of ₹9.09 Cr (up 15% YoY) for FY 2024.
Revenue · FY 2024
₹9.09 Cr ▲ 15%
Net loss · FY 2024
₹73.15 Lakh margin -8%
EBITDA · FY 2024
₹1.07 Cr margin 11.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 15%
3 years · compounded
▲ 984%
EBITDA CAGR growth
1 year
▼ 38%
3 years · compounded
▲ 253%
Revenue has grown at a compounded annual rate (CAGR) of 984% over three years, including 15% growth in the latest year. EBITDA fell 38% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.07 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹73.15 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.8% | ||||
| Net Profit Margin | -8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Natcure Biotech Private Limited, buy the company report.
Board of directors of Natcure Biotech Private Limited
Natcure Biotech has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shyam Sundar Agrawal | Director | 19 Jun 2019 | 7 Years 4 Months | Current |
| Anil Kumar Singh | Director | 19 Jun 2019 | 7 Years 4 Months | Current |
| Piyush Agrawal | Director | 19 Oct 2020 | 6 Years 0 Months | Current |
| Bhaskar Dey | Director | 19 Oct 2020 | 6 Years 0 Months | Current |
Peer comparison
Natcure Biotech Private Limited is compared with the 6 companies closest to it by revenue in the Healthcare industry (Alternative Medicine), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Holistic Remedies Pvt Ltd | ₹14.29 Cr (FY 2025) | -8.0% | Thane, Maharashtra, India | |||
| Nivoxaa Biotech India Private Limited | ₹10.97 Cr (FY 2024) | 37.0% | Karnal, Haryana, India | |||
| Natcure Biotech Private Limitedthis company | ₹9.09 Cr (FY 2024) | -₹73.15 Lakh | -8% | 15.0% | 98 | Raipur, Chhattisgarh, India |
| Hapro Homeo-Chem P Ltd | ₹8.41 Cr (FY 2025) | 9.0% | Thane, Maharashtra, India | |||
| Healwell Homeo Private Limited | ₹7.96 Cr (FY 2024) | -5.0% | Mehesana, Gujarat, India | |||
| Bio-India Pharma Private Limited | ₹6.75 Cr (FY 2024) | -1.0% | Mumbai, Maharashtra, India | |||
| KJ Laboratories (OPC) Private Limited | ₹6.36 Cr (FY 2025) | 47.0% | Allahabad, Uttar Pradesh, India |
To see the full peer comparison of Natcure Biotech Private Limited, buy the company report.
Auditor
Natcure Biotech Private Limited is audited by AGRAWAL MAHENDRA & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AGRAWAL MAHENDRA & CO | FY 2022 | 322273C |
Shareholding
The shareholding of Natcure Biotech Private Limited is on record for 3 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Natcure Biotech Private Limited, buy the company report.
Charges & borrowings
Open charges
₹8.08 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 Sep 2021 | 100480606 | Others | ₹8.08 Cr | Open |
Total charge records: 1 View all charges
Legal cases
Natcure Biotech Private Limited has 2 court cases on record: 2 filed by Natcure Biotech. 1 case is pending and 1 is disposed.
Total cases
2
Filed by the company
2
Pending
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 0 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Raipur, Chhattisgarh | Court case (COMPLAINT CASES) | Filed by the company against an individual | Pending |
| District court, Raipur, Chhattisgarh | Court case (COMPLAINT CASES) | Filed by the company against an individual | Disposed |
To see the full case history of Natcure Biotech Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Natcure Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Natcure Biotech Private Limited has a workforce of 98 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
Employee count
98
Active EPFO establishments
1
Employee growth
36.11%
GST
Natcure Biotech has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 22AAGCN5770R1ZV | Chhattisgarh | Active | 03 Aug 2019 |
To see the full GST registrations and return filing status of Natcure Biotech Private Limited, buy the company report.
Recent activity
Natcure Biotech Private Limited has 5 board changes on record since 2019: 4 appointments and 1 cessation. The latest: Anil Bhutani ceased to be Director on 29 Oct 2022.
AGM
Natcure Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Natcure Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chhattisgarh.
Ceased
Anil Bhutani ceased to be Director.
Charges
A charge with Others amounted to Rs. 8.08 Cr with Charge ID 100480606 was registered on 17 Sep 2021.
Appointed
Bhaskar Dey was appointed as Director.
Appointed
Piyush Agrawal was appointed as Director.
Appointed
Anil Kumar Singh was appointed as Director.
Appointed
Shyam Sundar Agrawal was appointed as Director.
Incorporation
19 Jun 2019
Natcure Biotech Private Limited was registered on 19 Jun 2019 with Roc Chhattisgarh & aged 7 years 4 months as per MCA records.
Frequently asked questions
Natcure Biotech is an active private limited company based in Raipur, Chhattisgarh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 19 June 2019 (7+ years old) and is registered under CIN U24110CT2019PTC009360.
Natcure Biotech has 4 current directors:
- Shyam Sundar Agrawal - Director
- Anil Kumar Singh - Director
- Piyush Agrawal - Director
- Bhaskar Dey - Director
The latest financial statements of Natcure Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Natcure Biotech is 22AAGCN5770R1ZV, registered in Chhattisgarh.
The CIN (Corporate Identification Number) of Natcure Biotech is U24110CT2019PTC009360. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Natcure Biotech has 2 court cases on record: 2 filed by the company. 1 is pending.
Natcure Biotech was incorporated on 19 June 2019, making it 7+ years old. It is registered with the Registrar of Companies, Chhattisgarh.
The peers of Natcure Biotech by revenue are Holistic Remedies Pvt Ltd, Nivoxaa Biotech India Private Limited, Hapro Homeo-Chem P Ltd, Healwell Homeo Private Limited, Bio-India Pharma Private Limited and 1 more, all in the Healthcare industry (Alternative Medicine), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Anil Bhutani ceased to be Director on 29 Oct 2022. Bhaskar Dey was appointed as Director on 19 Oct 2020. Piyush Agrawal was appointed as Director on 19 Oct 2020. Natcure Biotech has 5 board changes on record in total.
Yes, Natcure Biotech is registered as a small enterprise under Udyam registration (number: UDYAM-CG-14-0045224).
Natcure Biotech can be reached through the website natcurebiotech.com. Its registered office is in Raipur, Chhattisgarh, India.